A longitudinal study of antioxidant status in phenylketonuric patients

Clinical Biochemistry

Volumn 37, Issue 3, 2004, Pages 198-203

  Artuch, Rafael ^a   Colomé, Catrina ^a   Sierra, Cristina ^a   Brandi, Nuria ^a   Lambruschini, Nilo ^a   Campistol, Jaume ^a   Ugarte, Dolores ^b   Vilaseca, Maria A ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

Antioxidant enzymes; Dietary treatment; Phenylketonuria; Selenium; Ubiquinone 10

Indexed keywords

ANTIOXIDANT; CATALASE; ENZYME; SELENIUM; UBIDECARENONE;

ADULT; AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; CHILD; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; OXIDATIVE STRESS; PHENYLKETONURIA; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 1242269949     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2003.10.017     Document Type: Article

References (27)

1. Scriver C.R., Kaufman C., Eisensmith R.C., Woo S.L.C. The hyperphenylalaninemias. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular basis of inherited disease. 8th ed. 2001;1667-1724 McGraw Hill, New York.
2. Przyrembel H., Bremer H.J. Nutrition, physical growth, and bone density in treated phenylketonuria. Eur. J. Pediatr. 159(Suppl. 2):2000;S129-S135.
3. Weglage J., Pietsch M., Funders B., Koch H.G., Ullrich K. Neurological findings in early treated phenylketonuria. Acta Paediatr. 84:1995;411-415.
4. Hanley W.B., Lee A.W., Hanley A.J.G.et al. Hypotyrosinemia in phenylketonuria. Mol. Gen. Metab. 69:2000;286-294.
5. Wyse A.T.S., Sarkis J.J.F., Cunha-Filo J.S.et al. Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem. Res. 19:1994;1175-1180.
6. Bauman M.L., Kemper T.L. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol. 58:1982;55-63.
7. Shefer S., Tint G.S., Jean-Guillaume D.et al. Is there a relationship between 3-hydroxy-3-methylglutaryl Coenzyme A reductase activity and forebrain pathology in the PKU mouse? J. Neurosci. Res. 61:2000;549-563.
8. Van Bakel M.M., Printzen G., Wermuth B., Wiesmann U.N. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am. J. Clin. Nutr. 72:2000;976-981.
9. Wilke B.C., Vidailhet M., Favier A.et al. Selenium glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation. Clin. Chim. Acta. 207:1992;137-142.
10. Artuch R., Vilaseca M.A., Moreno J., Lambruschini N., Cambra F.J., Campistol J. Decreased serum ubiquinone-10 concentration in phenylketonuria. Am. J. Clin. Nutr. 70:1999;892-895.
11. Artuch R., Colomé C., Vilaseca M.A.et al. Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. J. Inherit. Metab. Dis. 24:2001;359-366.
12. Colomé C., Artuch R., Vilaseca M.A.et al. Lipophilic antioxidants in phenylketonuric patients. Am. J. Clin. Nutr. 77:2003;185-188.
13. Kienzle Hagen M.E., Pederzolli C.D., Sgaravatti A.M.et al. Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim. Biophys. Acta. 1586:2002;344-352.
14. Ercal N., Aykin-Burns N., Gurer-Orhan H., McDonald J.D. Oxidative stress in a phenylketonuria animal model. Free Radic. Biol. Med. 32:2002;906-911.
15. Acosta P.B., Yannicelli S. Plasma micronutrient concentrations in infants undergoing for pheylketonuria. Biol. Trace Elem. Res. 67:1999;75-84.
16. Wendel U., Ullrich K., Schmidt H., Batzler U. Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations. Eur. J. Pediatr. 149:1990;13-16.
17. Wheeler C.R., Salzman J.A., Elsayed N.M., Omaye S.T., Korte D.W. Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Anal. Biochem. 208:1990;119-126.
18. Plagia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-169.
19. Mc Cord J.M., Fridovich Y. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
20. Spooner R.J., Delides A., Goldberg D.M. Heat stability and kinetic properties of human serum glutathione reductase activity in various disease states. Biochem. Med. 26:1981;239-248.
21. Johansson L.H., Borg L.A.H. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal. Biochem. 174:1988;331-336.
22. Finckh B., Kontush A., Commentz J., Hübner C., Burdelski M., Kohlschütter A. Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. Anal. Biochem. 232:1995;210-216.
23. Sierra C., Pastor M.C., de Ramon M.C. Liquid chromatography determination of alpha-tocoferol in erythrocytes. Clin. Chim. Acta. 208:1992;119-126.
24. Lloyd B., Holt P., Delves H.T. Determination of selenium in biological samples by absorption spectroscopy. Analyst. 107:1982;927-933.
25. Halliwell B. Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem. Soc. Trans. 24:1996;1023-1027.
26. Colomé C., Artuch R., Lambruschini N., Cambra F.J., Campistol J., Vilaseca M.A. Is there a relationship between plasma phenylalanine and cholesterol in phenylketonuric patients under dietary treatment? Clin. Biochem. 34:2001;373-376.
27. Castillo M., Martinez-Cayuela M., Zafra M.F., Garcia-Peregrin E. Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis. Mol. Cell. Biochem. 105:1991;21-25.